Subsense secures $10m to advance BCI R&D efforts
Subsense emerged from stealth in February 2025 and is developing a nanoparticle-based brain-computer interface (BCI).
Subsense emerged from stealth in February 2025 and is developing a nanoparticle-based brain-computer interface (BCI).
Companies must maintain the highest safety standards if they want consumer trust.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Medical Technology is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
What does the EU Data Act mean for businesses?
GE HealthCare launches new ultrasound system for cardiovascular imaging
AI psychosis sees users ‘co-creating delusions with technology’ – expert
Tempus to acquire AI digital pathology company Paige